No Impact of Corticosteroid Use During the Acute Phase on Persistent Symptoms Post-COVID-19

Persistent COVID-19 symptoms may be related to residual inflammation, but no preventive treatment has been evaluated. This study aimed to analyze, in a prospective cohort, whether corticosteroid use in the acute phase of COVID-19 in hospitalized patients may reduce the risk of persistent COVID-19 sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan Sui Ko, Adrien, Candellier, Alexandre, Mercier, Marie, Joseph, Cedric, Carette, Hortense, Basille, Damien, Lion-Daolio, Sylvie, Devaux, Stephanie, Schmit, Jean-Luc, Lanoix, Jean-Philippe, Andrejak, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394663/
https://www.ncbi.nlm.nih.gov/pubmed/36003084
http://dx.doi.org/10.2147/IJGM.S367273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394663/
https://www.ncbi.nlm.nih.gov/pubmed/36003084
http://dx.doi.org/10.2147/IJGM.S367273

Ejemplares similares